In tumors, C–C motif chemokine receptor-like 2 (CCRL2) enhances TLR4-mediated inflammatory signaling by interacting with membrane TLR4, thereby enhancing anti-tumor T cell responses [15]. This evidence concerns the gene CCRL2 and neoplasm.